Log in to save to my catalogue

C73 NEW MECHANISMS AND THERAPIES IN COPD: Effect Of Interleukin 13 On Human Tracheal Epithelial Cell...

C73 NEW MECHANISMS AND THERAPIES IN COPD: Effect Of Interleukin 13 On Human Tracheal Epithelial Cell...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1926716490

C73 NEW MECHANISMS AND THERAPIES IN COPD: Effect Of Interleukin 13 On Human Tracheal Epithelial Cells

About this item

Full title

C73 NEW MECHANISMS AND THERAPIES IN COPD: Effect Of Interleukin 13 On Human Tracheal Epithelial Cells

Publisher

New York: American Thoracic Society

Journal title

American journal of respiratory and critical care medicine, 2017-01, Vol.195

Language

English

Formats

Publication information

Publisher

New York: American Thoracic Society

More information

Scope and Contents

Contents

Corresponding author's email: oliver.wittekindt@uni-ulm.de Interleukin 13 (IL-13) plays a pivotal role in exacerbating inflammatory lung diseases such as COPD and asthma and compromises lung epithelial barriers (Saatian et al., Tissue Barriers 1:2, 2013). [...]IL-13 specifically affects TJ organisation.

Alternative Titles

Full title

C73 NEW MECHANISMS AND THERAPIES IN COPD: Effect Of Interleukin 13 On Human Tracheal Epithelial Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1926716490

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1926716490

Other Identifiers

ISSN

1073-449X

E-ISSN

1535-4970

How to access this item